Congratulations!
For the 2nd consecutive year, LEBM has once again been selected to represent Taiwan’s biomedical innovation sector at the 2025 Japan–Taiwan Innovation Summit in Tokyo!
For the 2nd consecutive year, LEBM has once again been selected to represent
Taiwan’s biomedical innovation sector at the 2025 Japan–Taiwan Innovation Summit in Tokyo!
For the 2nd consecutive year, LEBM has once again been selected to represent Taiwan’s biomedical innovation sector at the 2025 Japan–Taiwan Innovation Summit in Tokyo!
LEBM (LE Biomedical Corp.) is a Taiwan Tech Arena (TTA)–backed HealthTech company founded in 2019 and headquartered in Taipei. We focus on the intersection of Wellness and AI, including ophthalmic care and nutraceuticals—advancing eye health and preventive wellness through functional contact lenses and a self-evolving, multi-agent “AI Scientist Team” system now in development.
Currently working with a leading optical group, we co-develop medical devices and new materials. By integrating optics, medicine, biotechnology, advanced materials, and artificial intelligence, we accelerate innovation and scale it to global markets.
“Vision Meets Nutrition with Intelligence.” We believe a clearer view of the world enables a healthier life. LEBM designs solutions that seamlessly combine nutraceuticals with smart technologies to improve human vision, whole-person wellness, and everyday living.
LEBM’s functional contact lenses combine nutraceuticals with advanced vision-correction technology.
⊹Patented Biotechnology
⊹Broad Use Cases
⊹A New Category in Eye Care
Beyond merely “correcting vision,” Nutri-Lenses redefine contact lenses as a daily platform for comprehensive eye-health management.
Inspired by a multi-agent architecture, our AI Scientist system integrates:
⊹Automated data ingestion & analysis
⊹Functional-material prediction & simulation
⊹Intelligent IP creation (e.g., patent drafting, prior-art mapping)
The result: shorter development cycles, stronger IP portfolios, and faster go-to-market for innovative medical devices—such as high-performance soft contact lenses.
In partnership with a lifestyle clinic, LEBM and LEBJ (Lifenergy Biotech Japan) operate 24/7, self gym that aims to integrate clinical know-how with AI-guided fitness recommendations in the future.
LePlus24 is a 24-hour self-service fitness gym equipped with the latest machines. Members can train without changing clothes or shoes, with men’s and women’s showers, changing rooms, and lockers available. The gym features high-quality VISION FITNESS machines (Johnson Health Tech), free Wi-Fi and a water server, optional monthly shoe lockers, and a supplement server (optional). Personal training is available through contracted trainers. Membership is handled online; plans include a Basic Membership, a U22 discount, and a One-Day Visitor Pass. Open 24 hours a day, 365 days a year.
The Ministry of Economic Affairs (MOEA) of Taiwan’s Executive Yuan awarded the “Pandemic Prevention Vanguard” trophy.
Obtained the first ISO 18184 antiviral melt-blown non-woven fabric test report/qualification in Asia.
Selected by TTA to exhibit at CES (Las Vegas) for two consecutive years.
Delivered a Japanese-language talk within the Osaka/Kansai innovation ecosystem (including activities with Osaka Innovation Hub).
Presented our contact-lens initiative in Kobe, Japan, at a local biomedical/innovation forum.
Represented TTA at the Japan–Taiwan Innovation Summit hosted by Startup Island Taiwan (SIT).
Began collaboration with an ophthalmology clinic in Tokyo to introduce functional contact lenses for childhood myopia control.
Initiated collaboration toward planning a Japan–Taiwan AI Lab with a Kumamoto semiconductor supply-chain partner and LLM expert at Academia Sinica.
LEBM CEO Dr. Sean Huang delivered the keynote speech at Chunghwa Telecom headquarters (March 2025): “Preparing for the New Era: Getting Ready for AGI” at the conference “AI 2025 Now & Next: Innovation in Operations and Industry Trends”.
Now and Future – Continue advancing the AI Scientist system and expanding applications in medical devices and new-material R&D.
We welcome collaborations with enterprises, AI developers, medical partners, distributors, and investors who share our vision of healthier living through technology.
Forward-looking statements. Terms such as “aim,” “plan,” “expect,” “intend,” and similar expressions are forward-looking and subject to risks and uncertainties. Actual results may differ, and LEBM undertakes no obligation to update these statements.
TEL:
+886-2-25112116
E-mail:
service@lebio.com.tw